$Marvell Technology(MRVL)$ 如果你认为： • AI 数据中心未来 5–10 年仍将高速扩张 • 云厂商一定会走“自研芯片 + 降本增效”路线 • 数据中心互连和定制 ASIC 是长期趋势 那么： • MRVL 是一个极具性价比的“AI 基础设施核心成长股”

$Affirm Holdings, Inc.(AFRM)$ 摩根士丹利（Morgan Stanley）将Affirm公司评为“最佳选择”。该投行在一份报告中指出，市场对私人信贷市场的担忧可能过度，且Affirm的盈利预期很有可能向上修正。分析师认为，解决私人信贷过剩问题的道路是可信的，且尚未看到任何证据表明Affirm的公共资产支持证券化交易的利差减弱。 摩根士丹利已将AFRM的评级定为“增持”，并认为其是覆盖范围内风险回报设置最具吸引力的公司之一，给出了76美元的目标价。这一积极评价显著提振了投资者信心，成为推动股价在交易时段内走强的主要动力。

$Stellantis NV(STLA)$ 汽车制造商斯泰兰蒂斯集团（Stellantis）与法国人工智能公司 Mistral AI 于周三在联合新闻稿中宣布，将扩大双方现有合作关系，以在斯泰兰蒂斯集团的各项业务运营中进一步推动人工智能应用

$Entero Therapeutics, Inc.(ENTO)$ (formerly First Wave BioPharma) is a clinical-stage biopharmaceutical company focused on developing orally delivered therapies for gastrointestinal (GI) diseases. The company’s innovative pipeline, which targets unmet needs in GI healthcare, provides several compelling reasons to consider it as an investment opportunity. Key Advantages: 1. Targeted Therapeutic Approach: Entero Therapeutics specializes in orally delivered biotherapeutics aimed at GI disorders, positioning itself in a growing market where the demand for novel treatments is increasing. Their lead drug candidates, including latiglutenase for celiac disease and adrulipase for exocrine pancreatic insufficiency, are undergoing Phase 2 trials . 2. Diver

In light of recent developments,$Standard Lithium(SLI)$ presents a compelling opportunity for investors seeking exposure to the rapidly growing electric vehicle (EV) and renewable energy sectors. On Friday, the Biden administration announced a major funding initiative aimed at boosting domestic production of critical materials for electric vehicles, with more than $3 billion allocated across 25 battery manufacturing projects in 14 states. Among the beneficiaries is SWA Lithium LLC, a joint venture between Standard Lithium and $Equinor ASA(EQNR)$, which has been awarded $225 million. This substantial grant underscores the importance of lithium as a strategic resource and positions Standard Lithium at t

Stock Recommendation:$Semler Scientific, Inc.(SMLR)$ Introduction to Semler Scientific (SMLR) Semler Scientific, Inc. (NASDAQ: SMLR) is a medical technology company focused on developing and marketing products for assessing chronic diseases. Known for its flagship product, QuantaFlo, the company has established a strong presence in the U.S. healthcare industry by providing solutions for early detection of vascular disease. SMLR’s products aim to improve patient outcomes, reduce healthcare costs, and support value-based care—a growing trend in the medical field. Market Position and Competitive Edge Semler’s niche focus on vascular disease diagnostics gives it a strong advantage in the healthcare technology sector. Unlike larger companies that may h

$SentinelOne, Inc(S)$ view order details.